These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25427000)

  • 1. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
    Du Q; Sun Y; Ding N; Lu L; Chen Y
    PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
    Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
    Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
    Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Blockers improve survival of patients with chronic obstructive pulmonary disease after coronary artery bypass grafting.
    Angeloni E; Melina G; Roscitano A; Refice S; Capuano F; Lechiancole A; Comito C; Benedetto U; Sinatra R
    Ann Thorac Surg; 2013 Feb; 95(2):525-31. PubMed ID: 23040827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-blocker is associated with lower mortality in patients with coronary artery disease with or without COPD.
    Rezaei SS; Rinner C; Ratajczak P; Grossmann W; Gall W; Wolzt M
    Clin Respir J; 2018 Dec; 12(12):2627-2634. PubMed ID: 30276967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
    Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
    Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
    Chapman KR; Wise RA; Scirica BM; Bhatt DL; Daoud SZ; Lythgoe D; Gil EG
    Respir Res; 2021 Oct; 22(1):272. PubMed ID: 34686204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
    Rasmussen DB; Lange P; Jensen MT
    Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
    Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
    BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker use and COPD mortality: a systematic review and meta-analysis.
    Etminan M; Jafari S; Carleton B; FitzGerald JM
    BMC Pulm Med; 2012 Sep; 12():48. PubMed ID: 22947076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.
    LaFon DC; Helgeson ES; Lindberg S; Voelker H; Bhatt SP; Casaburi R; Cassady SJ; Connett J; Criner GJ; Hatipoglu U; Kaminsky DA; Kunisaki KM; Lazarus SC; McEvoy CE; Reed RM; Sciurba FC; Stringer W; Dransfield MT
    JAMA Netw Open; 2024 May; 7(5):e247535. PubMed ID: 38771577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-blocker prescription and chronic obstructive pulmonary disease].
    Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
    Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.